Skip to main content
OpenTrials

Clinical trial condition

Neurotoxicity Syndromes

Explore clinical trials studying Neurotoxicity Syndromes. Study availability and eligibility vary by location and protocol.

94 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Neurotoxicity Syndromes trial results

Completed

Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia

NCT00437060

Conditions
Chemically-Induced Disorders, Childhood B Acute Lymphoblastic Leukemia, Childhood T Acute Lymphoblastic Leukemia, +8 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Southern California Permanente Medical Group Downey, California, United States
  • Miller Children's and Women's Hospital Long Beach Long Beach, California, United States
View all 112 locations
View Trial Details
Completed

Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

NCT00489411

Conditions
Chemically-Induced Disorders, Nervous System Diseases, Neurologic Manifestations, +10 more
Locations
  • Kaiser Permanente - Deer Valley Antioch, California, United States
  • Alta Bates Summit Comprehensive Cancer Center Berkeley, California, United States
  • Peninsula Medical Center Burlingame, California, United States
  • East Bay Radiation Oncology Center Castro Valley, California, United States
View all 475 locations
View Trial Details
Completed

Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer

NCT02311907

Conditions
Adnexal Diseases, Chemically-Induced Disorders, Chemotherapeutic Agent Toxicity, +37 more
Locations
  • Providence Hospital Mobile, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Northbay Cancer Center Fairfield, California, United States
View all 390 locations
View Trial Details
Completed

Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery

NCT00316914

Conditions
Chemically-Induced Disorders, Colonic Diseases, Colonic Neoplasms, +16 more
Locations
  • MBCCOP - Medical College of Georgia Cancer Center Augusta, Georgia, United States
  • Mercy Capitol Hospital Des Moines, Iowa, United States
  • CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States
  • John Stoddard Cancer Center at Iowa Methodist Medical Center Des Moines, Iowa, United States
View all 14 locations
View Trial Details
Completed

Acute Pain Caused by Paclitaxel in Patients With Cancer

NCT00860041

Conditions
Chemically-Induced Disorders, Chemotherapeutic Agent Toxicity, Nervous System Diseases, +8 more
Locations
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
  • St. Anthony Central Hospital Denver, Colorado, United States
View all 279 locations
View Trial Details
Completed

Vitamin E in Preventing Peripheral Neuropathy Caused by Chemotherapy in Patients Receiving Chemotherapy for Cancer

NCT00363129

Conditions
Chemically-Induced Disorders, Nervous System Diseases, Neurotoxicity, +3 more
Locations
  • St. Joseph Medical Center Bloomington, Illinois, United States
  • Graham Hospital Canton, Illinois, United States
  • Memorial Hospital Carthage, Illinois, United States
  • Eureka Community Hospital Eureka, Illinois, United States
View all 69 locations
View Trial Details

Related conditions